New Zealand funds their medicine through PHARMAC, a crown entity that determines and negotiates which essential medicine will be funded with their limited budget. The budget, given by the NZ government, was 71 million for 2022 and 120 million for 2023. PHARMAC has a committee called the Pharmacology and Therapeutics Advisory Committee (PTAC) that will choose which medicine to fund based on the demand, cost-effectiveness of the medicine and other factors. The PTAC will also take into account the quality and length of lives would be with or without the medicine. Currently, they fund over 1,300 different chemicals in 3,300 different presentations. People can put in applications to request a medicine to be funded in NZ – medicine would ideally present a clear benefit for New Zealanders with a deal with the medicine supplier to be approved by PTAC.
Does access to medicines differ from access to healthcare? Experiences of barriers to medicines access by people facing social disadvantage
Does access to medicines differ from access to healthcare? Experiences of barriers to medicines access by people facing social disadvantage
Levesque et al.’s widely-cited five dimensional model of access to healthcare has been used in a variety of contexts, including access to medicines.
